Free Trial

Bicara Therapeutics (BCAX) Insider Trading & Ownership

Bicara Therapeutics logo
$22.91 +0.91 (+4.14%)
(As of 10:46 AM ET)

Bicara Therapeutics (NASDAQ:BCAX) Insider Buying and Selling Activity

Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$34.25 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get BCAX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bicara Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BCAX Insider Buying and Selling by Quarter

Bicara Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/17/2024James E FlynnMajor ShareholderBuy70,000$18.00$1,260,000.00  
9/16/2024Ra Capital Management, L.P.DirectorBuy1,833,000$18.00$32,994,000.00  
(Data available from 1/1/2013 forward)

BCAX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Bicara Therapeutics includes James E Flynn, and Ra Capital Management, L.P.. Learn more on insiders at BCAX.

The following insiders have purchased BCAX shares in the last 24 months: James E Flynn ($1,260,000.00), and Ra Capital Management, L.P. ($32,994,000.00).

Insiders have purchased a total of 1,903,000 BCAX shares in the last 24 months for a total of $34,254,000.00 bought.

Bicara Therapeutics Key Executives

  • Ms. Claire Mazumdar Clemon M.B.A. (Age 35)
    Ph.D., CEO & Director
    Compensation: $650k
  • Mr. Ryan Cohlhepp Pharm.D. (Age 48)
    President, COO & Director
    Compensation: $660k
  • Mr. Ivan Hyep M.B.A. (Age 40)
    Chief Financial Officer
    Compensation: $597.5k
  • Ms. Lara S. Meisner J.D. (Age 52)
    Chief Legal Officer & Corporate Secretary
  • Ms. Rachel Salazar
    SVP of R&D Strategy and Operations
  • Ms. Sathish Hasige Ph.D.
    Senior VP and Head of Technical Operations & Supply Chain
  • Dr. David Raben M.D. (Age 61)
    Chief Medical Officer
  • Ms. Angela Windt
    VP & Head of Regulatory Affairs
  • Dr. Jeltje Schulten M.B.A.
    M.D., Senior Vice President of Clinical & Medical Affairs
  • Mr. Jean-Paul Rodrique
    Senior Vice President of Quality


This page (NASDAQ:BCAX) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners